MedTrace Logo

Screening for Obstructive Sleep Apnea in Medical Patients

NCT05980936 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2025-02-25

No results posted yet for this study

Summary

Obstructive sleep apnea (OSA) is highly prevalent in the general population and is associated with multiple adverse cardiovascular consequences.

Screening for OSA is recommended in those with typical symptoms, such as daytime sleepiness, loud snoring, or abrupt awakenings with gasping or choking. Patients admitted to the general medical wards with these symptoms will be evaluated for the possibility of having OSA.

Conditions

Interventions

OTHER

Screening for obstructive sleep apnea

Patient will be interviewed and asked of there are symptoms of snoring, day somnolence, chocking or gasping during sleep

Sponsors & Collaborators

  • Jordan Collaborating Cardiology Group

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-15
Primary Completion
2025-02-15
Completion
2025-02-22

Countries

  • Jordan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05980936 on ClinicalTrials.gov